Oncology & Cancer
New trial shows immunotherapy post-surgery improves overall survival for kidney cancer
For the first time in fifty years, results from a Phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer.
5 hours ago
0
0